<unk>  is an anticonvulsant, gamma aminobutyric acid Uptake Inhibitor that is FDA approved for the treatment of partial seizures in adults and children > 12 years.   Common adverse reactions include pruritus, abdominal pain, nausea, asthenia, ataxia, confusion, disturbance in speech, dizziness, feeling nervous, insomnia, somnolence, tremor, unable to concentrate and pharyngitis.
Tiagabine
Retigabine
Ezogabine
Pivagabine
Mesuximide
Ethosuximide
Brivaracetam
Methsuximide